Previous close | 51.16 |
Open | 40.59 |
Bid | 63.40 |
Ask | 67.40 |
Strike | 70.00 |
Expiry date | 2024-06-21 |
Day's range | 51.16 - 51.16 |
Contract range | N/A |
Volume | |
Open interest | 34 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.